Advertisement


Related Videos

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement



Dec
02
Today In Oncology
Lung Cancer Screening May Increase Long-Term Survival Rate
High Deductibles May Discourage Patients From Receiving Additional Testing After an Abnormal Mammogram
Study Finds Americans Have a Low Awareness of the Link Between Alcohol Use and Increased Cancer Risk
Does CBD Oil Improve Symptom Distress in Patients With Advanced Cancer Receiving Palliative Care
Incidence of Cervical Cancer in Women in the United States 2001 to 2019
View More 
Advertisement
© 2022 HSP News Service, L.L.C.
Designed by Harborside